ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.

Lei Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.